MX2010013135A - Procedimiento y dispositivo mejorados para favorecer el trasplante de material biológico. - Google Patents

Procedimiento y dispositivo mejorados para favorecer el trasplante de material biológico.

Info

Publication number
MX2010013135A
MX2010013135A MX2010013135A MX2010013135A MX2010013135A MX 2010013135 A MX2010013135 A MX 2010013135A MX 2010013135 A MX2010013135 A MX 2010013135A MX 2010013135 A MX2010013135 A MX 2010013135A MX 2010013135 A MX2010013135 A MX 2010013135A
Authority
MX
Mexico
Prior art keywords
transplant
facilitating
cells
biological material
improved device
Prior art date
Application number
MX2010013135A
Other languages
English (en)
Inventor
Rafael Alejandro Valdes Gonzalez-Salas
Annette Gisela Ortiz Austin
Original Assignee
Val De Bio S De R L De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Val De Bio S De R L De C V filed Critical Val De Bio S De R L De C V
Priority to MX2010013135A priority Critical patent/MX2010013135A/es
Priority to CA2819482A priority patent/CA2819482A1/en
Priority to US13/990,621 priority patent/US20140154299A1/en
Priority to JP2013541939A priority patent/JP2014509205A/ja
Priority to SG2013041496A priority patent/SG190436A1/en
Priority to EA201390805A priority patent/EA201390805A1/ru
Priority to PCT/MX2011/000116 priority patent/WO2012074349A1/es
Priority to AU2011337380A priority patent/AU2011337380A1/en
Priority to BR112013013554A priority patent/BR112013013554A2/pt
Priority to EP11845231.7A priority patent/EP2647351A1/en
Publication of MX2010013135A publication Critical patent/MX2010013135A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)

Abstract

La presente invención se refiere a un dispositivo plano o aplanado mejorado para favorecer el trasplante de células, que al ser insertado en el tejido subcutáneo, es recubierto por fibrocolágena, generando un sitio inmunológicamente privilegiado en su interior, útil como reservorio neovascularizado para el trasplante de células productoras de factores biológicos, para el tratamiento de enfermedades, tales como la Diabetes mellitus, CNS, o para trasplante de células sensibilizadas contra tumores.
MX2010013135A 2010-11-30 2010-11-30 Procedimiento y dispositivo mejorados para favorecer el trasplante de material biológico. MX2010013135A (es)

Priority Applications (10)

Application Number Priority Date Filing Date Title
MX2010013135A MX2010013135A (es) 2010-11-30 2010-11-30 Procedimiento y dispositivo mejorados para favorecer el trasplante de material biológico.
CA2819482A CA2819482A1 (en) 2010-11-30 2011-10-03 Flat device for facilitating the transplant of biological material
US13/990,621 US20140154299A1 (en) 2010-11-30 2011-10-03 Flat device for facilitating the transplant of biological material
JP2013541939A JP2014509205A (ja) 2010-11-30 2011-10-03 生体材料の移植を容易にする平坦なデバイス
SG2013041496A SG190436A1 (en) 2010-11-30 2011-10-03 Flat device for facilitating the transplant of biological material
EA201390805A EA201390805A1 (ru) 2010-11-30 2011-10-03 Усовершенствованные процедура и устройство для облегчения имплантации биологического материала
PCT/MX2011/000116 WO2012074349A1 (es) 2010-11-30 2011-10-03 Dispositivo plano para favorecer el trasplante de material biológico
AU2011337380A AU2011337380A1 (en) 2010-11-30 2011-10-03 Flat device for facilitating the transplant of biological material
BR112013013554A BR112013013554A2 (pt) 2010-11-30 2011-10-03 dispositivo plano para favorecer o implante de material biológico
EP11845231.7A EP2647351A1 (en) 2010-11-30 2011-10-03 Flat device for facilitating the transplant of biological material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2010013135A MX2010013135A (es) 2010-11-30 2010-11-30 Procedimiento y dispositivo mejorados para favorecer el trasplante de material biológico.

Publications (1)

Publication Number Publication Date
MX2010013135A true MX2010013135A (es) 2012-05-31

Family

ID=46172110

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010013135A MX2010013135A (es) 2010-11-30 2010-11-30 Procedimiento y dispositivo mejorados para favorecer el trasplante de material biológico.

Country Status (10)

Country Link
US (1) US20140154299A1 (es)
EP (1) EP2647351A1 (es)
JP (1) JP2014509205A (es)
AU (1) AU2011337380A1 (es)
BR (1) BR112013013554A2 (es)
CA (1) CA2819482A1 (es)
EA (1) EA201390805A1 (es)
MX (1) MX2010013135A (es)
SG (1) SG190436A1 (es)
WO (1) WO2012074349A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3290061T1 (sl) 2009-08-28 2020-09-30 Sernova Corporation Postopki in naprave za celično transplantacijo
WO2020041446A1 (en) 2018-08-22 2020-02-27 Boston Scientific Scimed Inc Cell encapsulation device including a porous tube

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298002A (en) * 1979-09-10 1981-11-03 National Patent Development Corporation Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation
US4378016A (en) * 1981-07-15 1983-03-29 Biotek, Inc. Artificial endocrine gland containing hormone-producing cells
US6773458B1 (en) * 1991-07-24 2004-08-10 Baxter International Inc. Angiogenic tissue implant systems and methods
CA2109065C (en) 1992-02-24 2004-03-30 Anton-Lewis Usala Bioartificial endocrine device
ATE208169T1 (de) * 1992-04-01 2001-11-15 Baxter Int Systeme zum einpflanzen von gefässbildendem gewebe
JPH08503715A (ja) 1993-09-24 1996-04-23 バクスター、インターナショナル、インコーポレイテッド 埋め込み装置の血管化を促進するための方法
ATE212230T1 (de) 1994-04-13 2002-02-15 Res Corp Technologies Inc Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
US6716246B1 (en) * 1998-12-15 2004-04-06 Universidad Nacional Autonoma De Mexico Process and device for facilitating the implantation of biological material
MX2007015736A (es) 2007-12-11 2009-06-11 Val De Bio S De R L De C V Procedimiento para sensibilizar celulas y el uso de las mismas para tratamiento de tumores.
EP4176888A1 (en) * 2008-11-14 2023-05-10 ViaCyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
SI3290061T1 (sl) * 2009-08-28 2020-09-30 Sernova Corporation Postopki in naprave za celično transplantacijo

Also Published As

Publication number Publication date
AU2011337380A1 (en) 2013-07-18
CA2819482A1 (en) 2012-06-07
WO2012074349A1 (es) 2012-06-07
JP2014509205A (ja) 2014-04-17
SG190436A1 (en) 2013-07-31
EA201390805A1 (ru) 2013-12-30
US20140154299A1 (en) 2014-06-05
BR112013013554A2 (pt) 2016-10-11
EP2647351A1 (en) 2013-10-09

Similar Documents

Publication Publication Date Title
MX2021001494A (es) Anticuerpos dkk1 y metodos de uso.
GEP20166429B (es)
GB201009222D0 (en) Improved cancer therapy based on tumour associated antigens derived from cyclin D1
MX2017001281A (es) Material anisotropico biocompuesto, implantes medicos que lo comprenden y metodos para el tratamiento del mismo.
GEP201706605B (en) Antibodies for epidermal growth factor receptor 3 (her3)
RU2014148136A (ru) Композиции т-клеток с недостаточностью рецепторов т-клеток
SG10201407281UA (en) Specific binding proteins and uses thereof
IN2012DN00446A (es)
WO2012019103A8 (en) System and apparatus for cell treatment
MX2011007930A (es) Conjugados de insulina cristalina.
MX343135B (es) Compuestos de tipo fumagilol y métodos de realización y uso de los mismos.
BR112013000433A2 (pt) diagnóstico e tratamento de câncer de mama
MY186456A (en) Quinazoline carboxamide azetidines
WO2012174276A3 (en) Compression device
EP2340258A4 (en) PROCESS FOR THE SYNTHESIS AND APPLICATIONS OF INHIBITORS OF GHRELIN-O-ACYLTRANSFERASE AS POTENTIAL THERAPEUTIC AGENTS AGAINST OBESITAS AND DIABETES
MY150600A (en) Use of opioid antagonists for treating urinary retention
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
WO2012048170A3 (en) Humanized animals via tissue engineering and uses therefor
IN2015DN01349A (es)
GB201201753D0 (en) Therapeutic agents with improved fibrinogen binding
IL207722A (en) Pyridopyrazinone Derivatives as Insulators, Methods of Preparation and Use for Diabetes
WO2013078376A3 (en) Isoxazole treatments for diabetes
MY162168A (en) Single-chamber vaporizer and use thereof in chemical synthesis
MX2010013135A (es) Procedimiento y dispositivo mejorados para favorecer el trasplante de material biológico.
WO2012018866A3 (en) Methods and compositions for the diagnosis and treatment of breast cancer

Legal Events

Date Code Title Description
FA Abandonment or withdrawal